https://investors.biontech.de/de/news-releases/news-release-details/pfizer-und-biontech-beginnen-phase-12-studie-mit-erstem-mrna
Piper Sandler Maintains Overweight on PayPal Holdings, Lowers Price Target to $93
Piper Sandler analyst Christopher Donat maintains PayPal Holdings (NASDAQ:PYPL) with a Overweight and lowers the price target from $140 to $93.